Search
for
Sort by
Research 91–120 of 1000+
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- The Monophenolic Antioxidant TS-13 Accelerates Hair Restoration in Mice with Chemotherapy-Induced Alopecia
- Chitosan Nanoparticles for Topical Drug Delivery in Chemotherapy-Induced Alopecia: A Comparative Study of Five Repurposed Pharmacological Agents
- Chemotherapy-Induced Alopecia by Docetaxel: Prevalence, Treatment and Prevention
- The effect of a helmet type, home-use low-level light therapy device for chemotherapy-induced alopecia: study protocol for a randomized controlled trial
- Prevention and Treatment of Chemotherapy-Induced Alopecia
- Expert consensus for prevention, diagnosis and management of persistent chemotherapy-induced alopecia.
- Persistent Alopecia in a Breast Cancer Patient Following Taxane Chemotherapy and Adjuvant Endocrine Therapy: Case Report and Review of Post-treatment Hair Loss in Oncology Patients with Breast Cancer
- A Review on Cryptorchidism-Induced Alopecia in Dogs
- The use of minoxidil to attempt to prevent alopecia during chemotherapy for gynecologic malignancies.
- 549 Temporary cell cycle arrest in human scalp hair follicles and their epithelial stem cells by ALRN-6924: A novel strategy to selectively protect p53-wildtype cells against paclitaxel-induced alopecia
- Chemically Induced Hair Loss/Alopecia
- Protective effect of Korean Red Ginseng against chemotherapeutic drug-induced premature catagen development assessed with human hair follicle organ culture model
- Distinctive histopathologic findings in linear morphea (<i>en coup de sabre</i>) alopecia
- Preventive effects of cedrol against alopecia in cyclophosphamide-treated mice
- An overview of management of drug-induced hair and nail disorders
- S100A8 induces cyclophosphamide-induced alopecia via NCF2/NOX2-mediated ferroptosis
- Efficacy of bimatoprost in treating chemotherapy-induced milphosis: A comprehensive review of randomized controlled trials
- iTRAQ-based quantitative proteomics revealing the therapeutic mechanism of a medicinal and edible formula YH0618 in reducing doxorubicin-induced alopecia by targeting keratins and TGF-β/Smad3 pathway
- Histopathology of non-scarring alopecia
- Alopecia and Hair Damage Induced by Oncological Therapy
- Nonscarring Alopecias
- Immune-related alopecia (areata and universalis) in cancer patients receiving immune checkpoint inhibitors
- Successful Treatment of Hair Loss and Restoration of Natural Hair Color in Patient with Alopecia Areata Due to Psychological Disorder Using Exosomes: Case Report with 6-Month Follow-Up
- A Guide to Assessing Damage Response Pathways of the Hair Follicle: Lessons From Cyclophosphamide-Induced Alopecia in Mice
- Resting no more: re‐defining telogen, the maintenance stage of the hair growth cycle
- Stigmatization caused by hair loss – a systematic literature review
- Alopecia due to chemotherapeutics, hedgehog inhibitors, targeted antibody therapies and immune checkpoint inhibitors
- Growth factors and cytokines in hair follicle development and cycling: recent insights from animal models and the potentials for clinical therapy
- Dissecting the Impact of Chemotherapy on the Human Hair Follicle